Long-term effects of selective immunolesions of cholinergic neurons of the nucleus basalis magnocellularis on the ascending cholinergic pathways in the rat: A model for Alzheimer's disease by Szigeti, Csaba et al.
RL
n
r
C
a
b
c
a
A
R
A
A
K
A
C
C
C
N
S
1
s
m
n
p
C
a
i
U
f
0
hBrain Research Bulletin 94 (2013) 9– 16
Contents lists available at SciVerse ScienceDirect
Brain  Research  Bulletin
jo u r n al hom epage : www.elsev ier .com/ locate /bra inresbul l
esearch  report
ong-term  effects  of  selective  immunolesions  of  cholinergic  neurons  of  the
ucleus  basalis  magnocellularis  on  the  ascending  cholinergic  pathways  in  the
at:  A  model  for  Alzheimer’s  disease
saba  Szigeti a,  Norbert  Bencsika, Aurel  Janos  Simonkab, Adam  Legradia,  Peter  Kasac, Karoly  Gulyaa,∗
Department of Cell Biology and Molecular Medicine, University of Szeged, Szeged, Hungary
Department of Traumatology, University of Szeged, Szeged, Hungary
Department of Psychiatry, University of Szeged, Szeged, Hungary
 r  t  i  c  l  e  i  n  f  o
rticle history:
eceived 10 November 2012
ccepted 7 January 2013
vailable online 26 January 2013
eywords:
ChE
hAT
holinergic cell loss
holinergic forebrain
ucleus basalis magnocellularis
aporin
a  b  s  t  r  a  c  t
Alzheimer’s  disease  is  associated  with  a signiﬁcant  decrease  in  the  cholinergic  input  to  the  neocor-
tex.  In a rat  model  of  this  depletion,  we  analyzed  the  subsequent  long-term  changes  in cholinergic
ﬁber  density  in  two well-deﬁned  areas  of the  frontal  and  parietal  cortices:  Fr1,  the  primary  motor  cor-
tex, and  HL,  the  hindlimb  area  of  the  somatosensory  (parietal)  cortex,  two  cortical  cholinergic  ﬁelds
that receive  inputs  from  the nucleus  basalis  magnocellularis  (nBM).  A  speciﬁc  cholinergic  lesion  was
induced  by  the  intraparenchymal  injection  of  192  IgG-saporin  into  the  nBM.  Choline  acetyltransferase
(ChAT)  immunohistochemistry  was  applied  to identify  the  loss  of  cholinergic  neurons  in  the  nBM,  while
acetylcholinesterase  (AChE)  enzyme  histochemistry  was  used  to analyze  the  decreases  in  the num-
ber of cholinoceptive  neurons  in the nBM  and  the  cholinergic  ﬁber  density  in  the  Fr1 and  HL  cortical
areas  in  response  to the  nBM  lesion.  The  immunotoxin  differentially  affected  the  number  of ChAT-  and
AChE-positive  neurons  in  the  nBM.  192  IgG-saporin  induced  a massive,  irreversible  depletion  of  the
ChAT-positive  (cholinergic)  neurons  (to 11.7%  of  the  control  level),  accompanied  by a less  dramatic,  but
similarly persistent  loss  of  the AChE-positive  (cholinoceptive)  neurons  (to 59.2%  of the  control  value)  in
the nBM  within  2 weeks  after the  lesion.  The  difference  seen  in the  depletion  of ChAT-  and  AChE-positive
neurons  is  due  to the speciﬁcity  of  the  immunotoxin  to  cholinergic  neurons.  The cholinergic  ﬁber den-
sities in  cortical  areas  Fr1  and  HL  remained  similarly  decreased  (to  62%  and  68%  of the  control  values,
respectively)  up to 20  weeks.  No  signiﬁcant  rebound  in AChE  activity  occurred  either  in  the  nBM  or  in
the  cortices  during  the  period  investigated.  This  study  therefore  demonstrated  that,  similarly  to  the  very
extensive reduction  in  the number  of  ChAT-positive  neurons  in  the nBM,  cortical  areas  Fr1  and  HL under-
went  long-lasting  reductions  in the  number  of  AChE-positive  ﬁbers  in  response  to  speciﬁc  cholinergic
lesioning  of  the nBM.. Introduction
The cholinergic basal forebrain, one of the diffusely projecting
ystems of the brain, comprising of the cholinergic neurons in the
edial septum, the vertical and horizontal limbs of the diago-
al band of Broca and the nucleus basalis magnocellularis (nBM),
rovides widespread innervation to the neocortex (Baxter and
hiba, 1999; Fitz et al., 2008; Kasa, 1986; Kasa et al., 1997; Kilgard
nd Merzenich, 1998; Wrenn and Wiley, 1998). The nBM receives
nputs from limbic and paralimbic structures and sends projections
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to the entire cortex (Mesulam et al., 1983). Degeneration of the
nBM gives rise to a number of profound morphological, biochem-
ical and functional effects directly related to the development of
Alzheimer’s disease (AD). The involvement of the cholinergic sys-
tem in AD has been documented extensively (Cuello et al., 2010;
Kasa et al., 1997; Mufson et al., 2008). The observation of the loss of
cholinergic neurons in the nBM, associated with a decreased level of
cortical cholinergic innervation and leading to the symptoms char-
acteristic of AD, has stimulated the development of animal models
involving a variety of techniques for lesioning of the nBM (Berger-
Sweeney et al., 1994, 2001; Mallet et al., 1995; Mohapel et al., 2005;
Wenk et al., 1994).The introduction of the use of 192 IgG-saporin, a highly
speciﬁc cholinergic immunotoxin, improved the speciﬁcity of
these studies (Book et al., 1994; Fitz et al., 2008; Wiley et al.,
1991). This immunotoxin consists of the monoclonal antibody
1 esearc
1
i
o
a
s
p
i
s
r
s
s
e
c
f
(
b
o
(
2
d
i
c
a
(
(
l
r
C
p
a
e
F
A
s0 C. Szigeti et al. / Brain R
92 IgG, disulﬁde-coupled to saporin, a member of the ribosome-
nactivating protein family derived from the plant Saponaria
fﬁcinalis. The antibody component is directed against rat p75,
 low-afﬁnity neurotrophin receptor protein, which ensures the
peciﬁcity of the toxin since only the cholinergic neurons express
75 in the nBM (Cuello et al., 1990). Following receptor binding and
nternalization, saporin enzymatically inactivates the large ribo-
omal subunit, thereby blocking protein synthesis and ultimately
esulting in cell death; the neurodegenerative process can be con-
idered complete in about 2 weeks (Wrenn and Wiley, 1998). Its
peciﬁcity makes 192 IgG-saporin a useful agent with which to
stablish speciﬁc cholinergic lesions modeling the AD-associated
holinergic hypofunction. Although deﬁcits in cholinergic function
ollowing several types of lesions to the nBM are well documented
Harati et al., 2008; Nag et al., 2009; Pizzo et al., 1999), there have
een only a few reports regarding the time course of the devel-
pment of this cholinergic hypofunction or its potential recovery
Abdulla et al., 1997; Höhmann and Coyle, 1988; Perry et al.,
001; Rossner et al., 1995a,b). Our present goal was therefore to
emonstrate the persistence of a 192 IgG-saporin-induced lesion
n the nBM and the long-term cortical response to this selective
holinergic neuron loss in architectonically well-deﬁned frontal
nd parietal cortical projection areas. Choline acetyltransferase
ChAT, EC 2.3.1.6) immunohistochemistry and acetylcholinesterase
AChE, EC 3.1.1.7) enzyme histochemistry were used to assess the
osses in the number of cholinergic and cholinoceptive neurons,
espectively, and the degree of cortical cholinergic innervation.
hAT-positive neurons were considered cholinergic, while AChE-
ositive neurons were considered cholinoceptive only as AChE
ctivity is also a common, but not obligatory, feature of most cholin-
rgic neurons (Butcher, 1995; Butcher and Woolf, 1984).
ig. 1. Location of the nBM and its investigated projection areas in the rat. The drawings
ChE  enzyme histochemistry on the control animals at approximately the same coordina
omatosensory cortex (according to the nomenclature of Zilles and Wree, 1995). The elliph Bulletin 94 (2013) 9– 16
2. Materials and methods
2.1. Animals
The experimental procedures were carried out in strict compliance with the
European Communities Directive 86/609/EEC, and followed the Hungarian leg-
islation requirements (XXVIII/1998 and 243/1998) and the University guidelines
regarding the care and use of laboratory animals. The experimental protocols involv-
ing  the participation of animals were approved by the Institutional Animal Welfare
Committee of the University of Szeged (I-74-II/2009/MÁB). Adult (150–180 g) male
Sprague-Dawley rats were obtained from the animal facility of the University. They
were maintained in-house under standard housing conditions (alone in their cages)
and  kept on a normal diet and tap water ad libitum with a 12-h light cycle (lights
on  at 7:00 a.m.).
2.2. Stereotaxic surgery and immunotoxin injection
Animals were deeply anesthetized with chloral hydrate (400 mg/kg, i.p., Reanal,
Hungary) and placed in a stereotaxic frame (Kopf Instruments, Tujunga, CA, USA)
with the incisor bar set 3.5 mm below the interaural line. A surgical incision was
made into the skin overlying the bregma and the scalp was pulled back with sur-
gical clips. With a dental drill, a hole was  made through the skull and a Hamilton
syringe was  lowered through this hole into the caudal portion of the nBM of the
basal  forebrain at the following coordinates (from the bregma): AP −2.8 mm,  ML
+3.8 mm,  DV −7.2 mm,  according to the stereotaxic atlas of Paxinos and Watson
(2007).  Control animals received 0.5 l of 0.1 M phosphate-buffered saline (PBS)
solution (810 ml  of 0.1 M Na2HPO4 and 190 ml of 0.1 M NaH2PO4 in 0.9% NaCl; pH
7.4), while treated animals received 0.5 l of 192 IgG-saporin (0.150 g in 1 l of
0.1  M PBS; Chemicon, Temecula, CA, USA). The immunotoxin or PBS solution was
pressure-injected over a period of 5 min. The needle was left in place for an addi-
tional 5 min  after the injection. The injection site, its tissue environment and the
investigated cortical projection areas of the nBM are depicted in Fig. 1.2.3. Tissue handling
Two, 4, 8, 12 or 20 weeks after the intranuclear injection into the nBM, the ani-
mals were deeply anesthetized and perfused transcardially with 150 ml of 0.1 M
PBS,  followed by 300 ml  of 4% formaldehyde in 0.1 M PBS, pH 7.4. The brains were
 (A and C) are taken from the atlas of Paxinos and Watson (2007).  Representative
tes is also shown (B and D). Fr1: frontal cortex area 1, HL: the hindlimb area of the
se marked with B (in both C and D panels) denotes the nBM. Scale bar: 500 m.
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Rig. 2. Quantitative assessment of the AChE-positive nerve ﬁbers in cortical areas
ontrol  Fr1 micrograph (A). The ﬁbers crossing the gridlines (B, white arrows) were
emoved, post-ﬁxed in the same ﬁxative for 4 h, cryoprotected in 30% sucrose solu-
ion for 12 h and embedded in cryomatrix (Shandon Scientiﬁc Ltd., Pittsburg, PA,
SA). Twenty-m-thick serial coronal sections were cut on a cryostat (Shandon
20 M;  Anglia Scientiﬁc Instruments Ltd., Cambridge, UK), mounted on gelatin-
oated slides and processed for enzyme histochemistry and immunohistochemistry.
o  assess the damage, induced by 192 IgG-saporin injection into the nBM, architec-
onically well-deﬁned areas from the frontal and parietal cortical areas (Fr1 and HL,
ccording to the nomenclature of Zilles and Wree, 1995) in the ascending cortical
holinergic pathway were selected for quantitative ChAT immunohistochemistry
nd AChE enzyme histochemistry. The quantitative analysis of the AChE-positive
scending cholinergic ﬁbers involved the entire Fr1 area (the primary motor cor-
ex), whereas for the HL area, the region proximal to the median-sagittal axis of the
rimary somatosensory cortex was used.
.4. ChAT immunohistochemistry
Cholinergic neurons were visualized by light microscopic ﬂuorescent immuno-
istochemistry. Following permeabilization and blocking in 0.05 M PBS containing
%  bovine serum albumin, 5% normal goat serum and 1% Triton X-100 for 30 min  at
7 ◦C, ChAT immunoreactivity was visualized by incubating the sections overnight
t  4 ◦C in the same buffer containing rabbit anti-ChAT primary antibody (1:200,
hemicon, Temecula, CA, USA). After incubation with Alexa ﬂuor 568-labeled goat
nti-rabbit secondary antibody (1:1000; Invitrogen, Carlsbad, CA, USA) for 3 h at
oom temperature (RT) in the dark, nucleus staining was carried out with 1.5 ml
f  Hoechst 33258 dye (Sigma, St. Louis, MO,  USA) dissolved in 3 ml of 1 mg/ml
olyvinylpyrrolidone in 0.1 M PBS. The tissue sections were dehydrated, covered
ith Vectashield (Vector Laboratories, Burlingame, CA, USA) and investigated under
n epiﬂuorescent microscope (Nikon Microphot FXA; Nikon, Tokyo, Japan).
.5. AChE enzyme histochemistry
For the demonstration of cholinoceptive neurons in the nBM and AChE-positive
bers in the cortices Fr1 and HL, 30-m-thick free-ﬂoating coronal sections were
ollected in 0.1 M sodium acetate buffer (pH 7.4). AChE-positive cells in the nBM
ere identiﬁed by a modiﬁed method of Koelle and Friedenwald (1949).  Brieﬂy, sec-
ions were incubated in 0.1 M sodium acetate buffer (pH 5.0) containing 0.072 mg/ml
f  ethopropazine, 0.075 g of glycine, 0.05 g of CuSO4 and 0.12 g of acetylthiocholine
odide for 4 h in the dark with gentle agitation on a rotating platform. Enzymatic
eactions were visualized in 4% Na2S in 0.1 M sodium acetate buffer (pH 5.0) for
0  min  in the dark. Sections were mounted, dehydrated and covered with di-n-butyl
hthalate in xylene (DPX; Fluka, Buchs, Switzerland) and investigated under a light
icroscope.
In  order to visualize the ﬁne network of cholinergic ﬁbers in the cortex, we
sed the rapid Martucciello method (Martucciello et al., 2001). Brieﬂy, sections were
mmersed into the incubation medium (0.1 M acetate buffer, 0.1 M sodium citrate,
 mg/ml  of acetylthiocholine iodide, 4 mM ethopropazine, 30 mM CuSO4, freshly
ade 5 mM K3Fe(CN)6; pH 6.0) for 1 h at RT. After a brief rinse in 0.1 M PBS, the
ections were developed with SIGMAFAST DAB with a metal enhancer (Sigma) for
 min  at RT. Sections were mounted, covered with glycerine/0.05 M PBS (3:1) and
nvestigated under a light microscope..6. Morphometry and statistical analysis
Representative microphotographs from the nBM and cortical areas Fr1 and
L  were taken with a digital microscope camera (Qimaging MicroPublisher 3.3
TV, Qimaging Inc., Surrey, BC, Canada) attached to a Leica DMLB microscopend HL. The counting grid with 200 m × 200 m squares superimposed over the
ted. Scale bars: 50 m (A) and 25 m (B).
(Leica Mikroskopie und Systeme GmbH, Wetzlar, Germany). Fluorescently labeled
cells were captured with a Spot camera (SPOT RT/ke, Diagnostic Instruments, Inc.,
Sterling Heights, MI,  USA) on a Nikon Microphot FXA epiﬂuorescent microscope
(Nikon, Tokyo, Japan). Image processing was achieved with QCapturePro 6.2 for
Windows (Qimaging Inc.) and SPOT Advanced software (Diagnostic Instruments,
Inc.). ChAT-immunopositive neurons and cells positive for AChE histochemistry
in  the nBM were identiﬁed in alternating consecutive sections of each of the
3  rats from both the control (saline-lesioned) and the 192 IgG-saporin-lesioned
groups. Labeled cells were counted with the use of ImageJ, a public domain
image processing and analysis program (version 1.38; developed at the U.S.
National Institutes of Health by W.  Rasband, and available from the Internet at
http://rsb.info.nih.gov/ij).
To quantify the extents of the consequences of the nBM lesions in cortical
areas Fr1 and HL, AChE-positive ﬁbers were counted according to previously pub-
lished methods (Kim et al., 2005; Stichel and Singer, 1987). Brieﬂy, a 3 × 3 counting
grid  consisting of 200 m squares for a total of 600 m × 600 m was  superim-
posed over the entire depths of cortices Fr1 and HL ipsilateral to the injection
and perpendicular to the pial surface. The density of AChE positive ﬁbers was
counted at a magniﬁcation of 100× and expressed as the number of ﬁbers cross-
ing the counting grid (Fig. 2) and compared across groups. For each animal, counts
were made in 3 non-overlapping but adjacent ﬁelds of view in 3 consecutive
brain sections, and averaged across the samples. Statistical analyses were car-
ried  out with SigmaStat 3.11 (Systat Software Inc., Chicago, IL, USA), a statistical
software package using ANOVA and the Holm–Sidak method for post hoc com-
parisons. Data are reported as mean ± S.D. Changes were considered signiﬁcant at
p  < 0.05.
3. Results
The effects of intraparenchymal 192 IgG-saporin injection into
the caudal part of the nBM were demonstrated by using the cholin-
ergic and cholinoceptive markers ChAT and AChE, respectively
(Fig. 3). The immunotoxin differentially affected ChAT- and AChE-
positive neurons in the nBM. The numbers of ChAT-expressing
neurons and AChE-positive cell somata in the nBM of the saline-
injected animals (Fig. 3A and C, respectively) were markedly
reduced 2 weeks after the lesion elicited by 192 IgG-saporin injec-
tion (Fig. 3B and D for ChAT- and AChE-positive cells, respectively).
The numbers of ChAT-positive cells in the nBM of the saline- and the
toxin-injected animals were 196 ± 0.8 and 23 ± 1.7, respectively.
Thus, 192 IgG-saporin had depleted the number of ChAT-expressing
neurons in the nBM to 11.7% of the control level by 2 weeks after the
injection (Fig. 4A). There was  no signiﬁcant change observed in the
number of ChAT-positive neurons up to 20 weeks postlesion (data
not shown). The number of AChE-positive cell somata in the nBM of
the saline-injected animals (24.0 ± 1.9) had decreased less dramat-
ically, to 59.2% of the control level (14.0 ± 1), by 2 weeks after the
saporin injection. The reduction was maintained at 4 (13.0 ± 3.7),
8 (12.6 ± 1.3), 12 (14.0 ± 1.4) and 20 (15.1 ± 0.2) weeks after the
immunotoxin injection (Fig. 4B).
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Fig. 3. Effects of the speciﬁc cholinergic lesioning of the nBM on the cholinergic and cholinoceptive neuronal components of the nBM and the cortical projection areas as
demonstrated by ChAT immunohistochemistry (A and B) and AChE enzyme histochemistry (C–F), respectively. The number of ChAT-expressing neurons in the control nBM
(A)  is markedly reduced 2 weeks after 192 IgG-saporin injection (B). The number of AChE-positive neurons decreased less dramatically 2 weeks postlesion in the nBM (D,
center)  relative to the nBM of the saline-injected (control) animals (C, center). AChE enzyme histochemistry also revealed a markedly reduced AChE-positive ﬁber density in
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The lesion-induced reductions in the cholinergic ﬁber density
f the cortical projection areas of the nBM are demonstrated in
ig. 3E and F. The cortical AChE-positive ﬁber densities in areas
r1 and HL (Fig. 5A and C) of the control (saline-injected) animals
ere 170.0 ± 7.5 and 186.15 ± 6, respectively. The 192 IgG-saporin-
licited speciﬁc cholinergic lesion resulted in similarly signiﬁcant
eductions in the AChE-positive ﬁber density (Fig. 5B and D). The
xtent of these reductions was very similar in both cortical regions
t all survival times investigated (Fig. 6). For example, at 2 weeks
fter the injection of 192 IgG-saporin into the nBM, the number
f AChE-positive ﬁbers in cortical area Fr1 was 76.5% of the con-
rol value (130.5 ± 2). At 4 weeks after the lesion, the number was
urther decreased to 67% of the control value (114.6 ± 1.4), and it
eached its minimum at 12 weeks (112.5 ± 9.6; 65% of the control).
n cortical area HL, the number of AChE-positive ﬁbers at 2 weeks
fter the lesion was 68% of the control value (128.0 ± 1.9); the min-
mum (116.9 ± 2.4) was attained at 4 weeks postlesion (62% of the
ontrol value).s compared with the same area of the control rats (E). Scale bars: 50 m (A and B)
4. Discussion
Small animal models are essential in understanding the path-
omechanism underlying neurodegenerative disorders (Brooks
et al., 2012; Hall and Roberson, 2012). Several animal studies
have established that selective lesioning of the cholinergic sys-
tem produced alterations similar to that seen in AD (Abdulla
et al., 1997; Berger-Sweeney et al., 2001; Fitz et al., 2008; Leanza
et al., 1995). The possibility of achieving selective induction of
the degeneration of cholinergic neurons in certain basal forebrain
structures in rodents led to the development of animal models
that mimic many biochemical, neuroanatomical and behavioral
aspects of AD (Galani et al., 2002; Leanza et al., 1995; Rossner
et al., 1995b; Walsh et al., 1995). Although the administration of
the potent neurotoxin 192 IgG-saporin to rats does not produce
all of the pathological features of AD (e.g., behavioral; Wenk et al.,
1994), its speciﬁc and permanent cholinergic cell destruction does
provide a reliable animal model with which to test hypotheses
C. Szigeti et al. / Brain Research Bulletin 94 (2013) 9– 16 13
Fig. 4. Quantitative analysis of the average numbers of ChAT- and AChE-expressing cells per tissue sections in the control and 192 IgG-saporin-lesioned nBM. The number of
ChAT-  and AChE-positive neurons were counted in 3 alternating consecutive sections of each of the 3 rats from both the control (saline-lesioned) and the 192 IgG-saporin-
lesioned  groups, and then averaged. The cholinergic cell population, assessed by ChAT immunohistochemistry, was decreased dramatically (to 11.7% of the control level) in
the  nBM 2 weeks after the injection (A). The cholinoceptive cell population, assessed by AChE enzyme histochemistry, also decreased over time (B) but in a less dramatic
manner. The signiﬁcant reduction (41%) observed 2 weeks after the 192-IgG-saporin lesion was  maintained throughout the experiment. The larges reduction (47.5%) was
seen  8 weeks postlesion (12.6 ± 1.3 AChE-positive cell somata per tissue section; 52.5% of the saline-injected value). *Data signiﬁcantly different from the control values
(p  < 0.05; ANOVA).
Fig. 5. Effects of 192 IgG-saporin injection on the AChE-positive (cholinoceptive) ﬁber density in cortical areas Fr1 and HL. Control rats (saline-injection to the nBM)
exhibited abundant network of AChE-positive ﬁbers in cortical areas Fr1 (A) and HL (C), while rats injected with 192 IgG-saporin into the nBM displayed a dramatically
reduced AChE-positive network in the cortical areas Fr1 (B) and HL (D) 20 weeks after the injection. Scale bar: 100 m.
14 C. Szigeti et al. / Brain Researc
Fig. 6. Time course of changes in the average numbers of AChE-positive (cholinocep-
tive) ﬁbers in the whole depths of the cortical areas Fr1 (ﬁlled circles) and HL (empty
circles) after 192 IgG-saporin lesion of the nBM. The number of ﬁbers crossing the
counting grid (described in Materials and methods) was counted in the whole depth
of  the cortices in 3 non-overlapping but adjacent ﬁelds of view in 3 consecutive
s
d
s
r
1
d
A
t
i
o
n
M
i
r
s
n
t
p
p
d
t
a
t
t
C
n
b
i
i
a
n
a
t
n
n
i
oections of 3 rats, and averaged. Note the persistent reduction in cholinergic ﬁber
ensity in both cortical areas, with no noticeable rebound at any time during the
tudy. *Data signiﬁcantly different from the control values (p < 0.05; ANOVA).
elating to the pathogenesis of AD (Fitz et al., 2008; Wiley et al.,
995).
The present study demonstrated that 192 IgG-saporin induced
ramatic and permanent decreases in the numbers of ChAT- and
ChE-positive neurons in the nBM 2 weeks after its unilateral injec-
ion into the nBM, and caused signiﬁcant, long-lasting decreases
n the densities of AChE-positive ﬁbers in cortices Fr1 and HL
f adult rats. A similar cholinergic ﬁber depletion in the human
eocortex is one of the characteristic features of AD (Geula and
esulam, 1989). The intranuclear injection of 192 IgG-saporin
nto the nBM destroyed nearly 90% of the ChAT-positive neu-
ons but only about half (41%) of the AChE-positive neuronal
omata in the nBM. The discrepancy in the number of affected
eurons indicates that not only cholinergic neurons are cholinocep-
ive (AChE-positive) in the nBM, but there are other neuronal
opulations here also that express AChE. Some of these AChE-
ositive neurons are resistant to the immunolesion because they
o not have p75, the low-afﬁnity neurotrophin receptor protein
hat ensures the speciﬁcity of the toxin to bind to and eventu-
lly kill the cholinergic neurons. Thus, the difference seen between
he number of destroyed ChAT- and AChE-positive neurons is due
o the speciﬁc binding of 192 IgG-saporin to the cholinergic (e.g.,
hAT-positive) but not to the cholinoceptive (e.g., AChE-positive)
eurons.
The topographical distribution of cholinergic neuronal cell
odies has been extensively studied in the rat CNS by ChAT
mmunohistochemistry and AChE histo- and immunohistochem-
stry. Although the correspondence, both in terms of distribution
nd morphology, between ChAT-containing and AChE-positive
eurons in most regions of the CNS is generally good, there are
 number of brain areas where these biomarkers do not label
he same cell (Satoh et al., 1983), e.g., the AChE-positive cells are
ot necessarily ChAT-positive. Thus, AChE as a biomarker could
ot exclusively be used to detect cholinergic neurons after the
mmunolesion in the nBM. Moreover, the subcellular distribution
f AChE in the principal cholinergic neurons of the brain generallyh Bulletin 94 (2013) 9– 16
follows a characteristic pattern which is different from that of
AChE-positive non-cholinergic neurons (Henderson, 1989).
Albeit some of the previous studies had similar results to that of
our present study, they were in many instances designed differently
as the number of biomarkers tested (both at the site of the lesion
and the projection areas), the route of administration, the amount
of immunotoxin used or the postlesion time was concerned. For
example, a single intracerebroventricular (i.c.v.) injection of 192
IgG-saporin into the caudal part of the nBM was  earlier reported
to result in a similarly irreversible and virtually complete deple-
tion in the number of ChAT-expressing neurons in this brain area
(Leanza et al., 1995), and to cause neurochemical alterations in the
hypothalamus and cortical areas that typically reﬂect a choliner-
gic hypofunction (Rossner et al., 1995b). 192 IgG-saporin was also
tested in lesioning other cholinergic components of the rat brain.
When injected i.c.v., the immunotoxin also selectively lesioned the
septal cholinergic neurons, resulting in consistently and signiﬁ-
cantly decreased AChE-positive ﬁber densities in various cortical
regions (Galani et al., 2002).
The cortical areas have extensive cholinergic innervation
(Butcher, 1995; Mesulam et al., 1983). We studied two  cholinergic
terminal ﬁelds with different functions after immunolesion to the
nBM. The cortical area Fr1 is part of the motor cortex in the rat and
has afferentation not only from the cholinergic forebrain, but also
from a wide range of other cerebral nuclei (Mesulam et al., 1983;
Zilles and Wree, 1995). Fr1 also has reciprocal connections with
the ipsi- and contralateral HL regions that are part of the primary
somatosensory cortex (Zilles and Wree, 1995). It must be empha-
sized, however, that these cortices retain a substantial proportion of
the cortical cholinergic ﬁbers after destruction of the ChAT-positive
neurons in the nBM as they provide approximately half of the
cholinergic inputs into the neocortex and amygdala (Wrenn and
Wiley, 1998). Apart from the extrinsic sources of the cholinergic
ﬁbers, cholinergic neurons intrinsic to the cortex have also been
indentiﬁed (see Lysakowsky et al., 1989, for further references);
this population can account for 30% or less of the cortical cholin-
ergic innervation (Johnson et al., 1981), and is not affected by the
immunolesion of the nBM.
In human AD brains, the numbers of AChE-positive cortical
ﬁbers are signiﬁcantly reduced in the frontal, parietal, tempo-
ral and visual cortices (Geula and Mesulam, 1989; Ridley et al.,
2005). The selective lesioning of nBM-derived cholinergic inputs
affected both motor and sensory functions associated with cortical
areas Fr1 and HL as our results from the saporin-induced animal
model of AD revealed signiﬁcant reductions in the Fr1 and HL
cortical AChE-positive ﬁber networks. The patterns of these reduc-
tions were similar in these two cortical areas. The reduction of the
AChE-positive ﬁbers in cortical areas Fr1 and HL were long-lasting:
we did not identify any subsequent signiﬁcant change (neither a
rebound nor a further decrease) in these cortical areas up to 20
weeks postlesion. It remains to be decided whether the slight and
non-signiﬁcant rebound in AChE-positive ﬁber density observed in
cortical areas Fr1 and HL at 20 weeks is due to compensatory mech-
anisms from cholinergic nuclei of basal forebrain areas other than
the nBM. Compensatory changes in the cortical cholinergic innerva-
tion from surviving neurons following the unilateral immunolesion
of the horizontal diagonal band of Broca have been documented
(Hartonian and de Lacalle, 2005). Selective immunolesion of cholin-
ergic neurons by the intraventricular injection of 192 IgG-saporin
could also result in long-term changes of other neurotransmitter
systems (Severino et al., 2007) that could, in turn, inﬂuence the
outcome of such compensatory mechanisms.For a clearer understanding of the neurodegenerative processes
that follow the destruction of the ascending cholinergic pathway in
general, and of the occurrence of any compensatory mechanisms
potentially involved in the regenerative processes in particular,
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hould additionally be investigated, as should the results after even
onger survival times. Moreover, recent advances in technologies
elated to in vivo imaging in small animals (e.g., PET) for the quan-
iﬁcation of amyloid plaques or certain cholinergic biomarkers will
nevitably led to a better understanding of the development of the
holinergic hypofunction (Manook et al., 2012; Parent et al., 2012).
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